Skyrizi 360 MG/2.4 ML on-body 2.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26FE9F2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,467
Award facts
- Contract value 100% obligated
- $12,467.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,467 to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Skyrizi 360 mg/2.4 mL on-body auto-injector doses. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999 through December 2026. The contract carries no set-aside designation and includes a completion date of January 12, 2026, with performance at the contractor's Conshohocken, Pennsylvania headquarters.
As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of brand-name and generic pharmaceuticals, specialty medications, vaccines, and medical devices to support military healthcare systems and other federal agencies. The Skyrizi product delivery under this order supports the company's ongoing role in providing specialized pharmaceutical products across multiple therapeutic domains through the DLA's global pharmaceutical supply chain. This award reflects AmerisourceBergen's established capability to fulfill federal medical supply requirements through competitive procurement and its position as a primary vendor within the Defense Health Agency's medical supply ecosystem.
Quick answers
Who was awarded contract SPE2DR26FE9F2?
SPE2DR26FE9F2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DR26FE9F2 worth?
The government has obligated $12,467 on SPE2DR26FE9F2.
Is contract SPE2DR26FE9F2 an order under another contract?
Yes. SPE2DR26FE9F2 is a delivery order under SPE2DR25D2005, an indefinite delivery contract.
Was contract SPE2DR26FE9F2 competed?
The extent of competition for SPE2DR26FE9F2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award